115 related articles for article (PubMed ID: 12921610)
21. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia.
Padró T; Ruiz S; Bieker R; Bürger H; Steins M; Kienast J; Büchner T; Berdel WE; Mesters RM
Blood; 2000 Apr; 95(8):2637-44. PubMed ID: 10753845
[TBL] [Abstract][Full Text] [Related]
22. [Estimation and clinical significance of serum soluble tumor necrosis factor receptors in patients with acute leukemia].
Lin M; Meng X
Zhonghua Xue Ye Xue Za Zhi; 1999 May; 20(5):245-8. PubMed ID: 11601213
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.
Bhatti SS; Kumar L; Dinda AK; Dawar R
Am J Hematol; 2006 Sep; 81(9):649-56. PubMed ID: 16845660
[TBL] [Abstract][Full Text] [Related]
24. Role of the microenvironment in promoting angiogenesis in acute myeloid leukemia.
Litwin C; Leong KG; Zapf R; Sutherland H; Naiman SC; Karsan A
Am J Hematol; 2002 May; 70(1):22-30. PubMed ID: 11994978
[TBL] [Abstract][Full Text] [Related]
25. [Angiogenesis in patients with hematologic malignancies].
Mesters RM; Padró T; Steins M; Bieker R; Retzlaff S; Kessler T; Kienast J; Berdel WE
Onkologie; 2001 Sep; 24 Suppl 5():75-80. PubMed ID: 11600818
[TBL] [Abstract][Full Text] [Related]
26. Tumor angiogenesis in the bone marrow of multiple myeloma patients and its alteration by thalidomide treatment.
Du W; Hattori Y; Hashiguchi A; Kondoh K; Hozumi N; Ikeda Y; Sakamoto M; Hata J; Yamada T
Pathol Int; 2004 May; 54(5):285-94. PubMed ID: 15086832
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of microvessel density in multiple myeloma patients.
Ahn MJ; Park CK; Choi JH; Lee WM; Lee YY; Choi IY; Kim IS; Lee WS; Ki M
J Korean Med Sci; 2001 Feb; 16(1):45-50. PubMed ID: 11289400
[TBL] [Abstract][Full Text] [Related]
28. Increased bone marrow microvascular density in haematological malignancies is associated with differential regulation of angiogenic factors.
Negaard HF; Iversen N; Bowitz-Lothe IM; Sandset PM; Steinsvik B; Ostenstad B; Iversen PO
Leukemia; 2009 Jan; 23(1):162-9. PubMed ID: 18800145
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of bone marrow angiogenesis in multiple myeloma.
Rajkumar SV; Leong T; Roche PC; Fonseca R; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Kyle RA; Gertz MA; Greipp PR
Clin Cancer Res; 2000 Aug; 6(8):3111-6. PubMed ID: 10955791
[TBL] [Abstract][Full Text] [Related]
30. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression.
Shang ZJ; Li JR
J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226
[TBL] [Abstract][Full Text] [Related]
31. [Expression of cyclooxygenase-2 in bone marrow cells of leukemia patients and its association with angiogenesis].
Liu XW; He QT; Li ZQ; Ma HJ; Li J; Jia GR; Lu Y; Han HY; Li Z; Yun Y; Zhang DX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):40-2. PubMed ID: 19236744
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathologic correlations of bone marrow angiogenesis in chronic myeloid leukemia: a morphometric study.
Korkolopoulou P; Viniou N; Kavantzas N; Patsouris E; Thymara I; Pavlopoulos PM; Terpos E; Stamatopoulos K; Plata E; Anargyrou K; Androulaki A; Davaris P; Yataganas X
Leukemia; 2003 Jan; 17(1):89-97. PubMed ID: 12529665
[TBL] [Abstract][Full Text] [Related]
33. Choice of endothelial marker is crucial for assessment of bone marrow microvessel density in chronic lymphocytic leukemia.
Smolej L; Kasparová P
APMIS; 2008 Dec; 116(12):1058-62. PubMed ID: 19133008
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
[TBL] [Abstract][Full Text] [Related]
35. Regulation of angiogenesis in the bone marrow of myelodysplastic syndromes transforming to overt leukaemia.
Keith T; Araki Y; Ohyagi M; Hasegawa M; Yamamoto K; Kurata M; Nakagawa Y; Suzuki K; Kitagawa M
Br J Haematol; 2007 May; 137(3):206-15. PubMed ID: 17408459
[TBL] [Abstract][Full Text] [Related]
36. Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia.
Wierzbowska A; Robak T; Wrzesień-Kuś A; Krawczyńska A; Lech-Marańda E; Urbańska-Ryś H
Eur Cytokine Netw; 2003; 14(3):149-53. PubMed ID: 14656688
[TBL] [Abstract][Full Text] [Related]
37. Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway.
Zhang J; Ye J; Ma D; Liu N; Wu H; Yu S; Sun X; Tse W; Ji C
Carcinogenesis; 2013 Mar; 34(3):667-77. PubMed ID: 23239744
[TBL] [Abstract][Full Text] [Related]
38. Study of prognostic significance of marrow angiogenesis assessment in patients with de novo acute leukemia.
AbdElAal Asmaa A; Afify RA; Zaher AE; ElGammal MM; Atef AM
Hematology; 2015 Oct; 20(9):504-10. PubMed ID: 25885121
[TBL] [Abstract][Full Text] [Related]
39. Soluble VEGF/sFLt1 ratio is an independent predictor of AML patient out come.
Aref S; El Sherbiny M; Goda T; Fouda M; Al Askalany H; Abdalla D
Hematology; 2005 Apr; 10(2):131-4. PubMed ID: 16019458
[TBL] [Abstract][Full Text] [Related]
40. [Flow cytometric analysis of bone marrow cell cycles in patients with hematologic diseases].
Meng FY; Ji H; Zhou Q
Zhonghua Nei Ke Za Zhi; 1992 May; 31(5):297-9, 318. PubMed ID: 1478130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
